A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease

[1]  R. Porcher,et al.  Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease , 2006, Thorax.

[2]  E. Hawe,et al.  +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease. , 2006, The American journal of clinical nutrition.

[3]  E. Hawe,et al.  Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease 1 – 3 , 2006 .

[4]  Tamara B Harris,et al.  Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[5]  E. Wouters,et al.  Body composition and mortality in chronic obstructive pulmonary disease. , 2005, The American journal of clinical nutrition.

[6]  Greg Atkinson,et al.  Reliability of maximal muscle force and voluntary activation as markers of exercise-induced muscle damage , 2005, European Journal of Applied Physiology.

[7]  D. Hansell,et al.  Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. , 2005, American journal of respiratory and critical care medicine.

[8]  E. Hawe,et al.  Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[9]  M. Polkey,et al.  Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease , 2004, European Respiratory Journal.

[10]  W. MacNee,et al.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.

[11]  C. O'Donnell,et al.  Body composition and resting energy expenditure in clinically stable, non-weight-losing patients with severe emphysema. , 2003, Chest.

[12]  M. Decramer,et al.  CHRONIC OBSTRUCTIVE PULMONARY DISEASE Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I , 2003 .

[13]  Emiel F M Wouters,et al.  Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. , 2003, Chest.

[14]  M. Polkey,et al.  Non-invasive mechanical ventilation improves walking distance but not quadriceps strength in chronic respiratory failure. , 2003, Respiratory medicine.

[15]  E. Wouters,et al.  Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. , 2003, Nutrition.

[16]  Suzanne G. Leveille,et al.  Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin‐6 Serum Levels , 2002, Journal of the American Geriatrics Society.

[17]  Y. Lacasse,et al.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. , 2002, American journal of respiratory and critical care medicine.

[18]  J. Vestbo,et al.  Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study , 2002, European Respiratory Journal.

[19]  J. Manson,et al.  Relation between markers of systemic vascular inflammation and smoking in women. , 2002, The American journal of cardiology.

[20]  Sally J. Singh,et al.  Bedside methods versus dual energy X‐ray absorptiometry for body composition measurement in COPD , 2002, European Respiratory Journal.

[21]  A. Ionescu,et al.  Inflammatory response and body composition in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[22]  E. Bozkanat,et al.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease , 2001, Respiratory research.

[23]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[24]  E. Wouters,et al.  Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids. , 2001, The European respiratory journal.

[25]  R. Casaburi.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. , 1999, Medicine and science in sports and exercise.

[26]  A. Goris,et al.  Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. , 2000, Respiratory medicine.

[27]  W. Frontera,et al.  Aging of skeletal muscle: a 12-yr longitudinal study. , 2000, Journal of applied physiology.

[28]  N. Hopkinson,et al.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. , 2009, American journal of respiratory and critical care medicine.

[29]  J. Vestbo,et al.  Prognostic value of nutritional status in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[30]  E. Wouters,et al.  Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[31]  F. Maltais,et al.  Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[32]  D. Brooks,et al.  The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. , 1998, Chest.

[33]  A. Young,et al.  Ageing and physiological functions. , 1997, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[34]  C. Pichard,et al.  Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. , 1997, American journal of respiratory and critical care medicine.

[35]  J. Martin,et al.  Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[36]  J. Janssens,et al.  Sniff nasal inspiratory pressure in patients with chronic obstructive pulmonary disease. , 1997, The European respiratory journal.

[37]  C. J. Clark,et al.  Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD. , 1996, The European respiratory journal.

[38]  M. Decramer,et al.  Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.

[39]  N. Jones,et al.  Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. , 1995, American journal of respiratory and critical care medicine.

[40]  E. Heikkinen,et al.  Muscle strength and mobility as predictors of survival in 75-84-year-old people. , 1995, Age and ageing.

[41]  E. Wouters,et al.  Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. , 1995, American journal of respiratory and critical care medicine.

[42]  E. Wouters,et al.  Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. , 1994, The European respiratory journal.

[43]  M. Decramer,et al.  Corticosteroids contribute to muscle weakness in chronic airflow obstruction. , 1994, American journal of respiratory and critical care medicine.

[44]  E. Wouters,et al.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.

[45]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[46]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[47]  E. Wouters,et al.  Within-day variation of bioelectrical resistance measurements in patients with chronic obstructive pulmonary disease. , 1990, Clinical nutrition.

[48]  S. H. Wilson,et al.  Predicted normal values for maximal respiratory pressures in caucasian adults and children. , 1984, Thorax.

[49]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[50]  D. Jones,et al.  Human skeletal muscle function: description of tests and normal values. , 1977, Clinical science and molecular medicine.